Stock Taper 
LYNX1 CAPITAL MANAGEMENT LP
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Denali Therapeutics Inc. | DNLI | 11.66K | $299.84K |
 Nuvation Bio Inc. | NUVB | 16.03K | $91.05K |
 Xencor, Inc. | XNCR | 18.19K | $292.92K |
 Absci Corporation | ABSI | 21.25K | $246.23K |
 CG Oncology Inc. | CGON | 31.39K | $2.23M |
 Entrada Therapeutics, Inc. | TRDA | 178.61K | $1.31M |
 Korro Bio, Inc. | KRRO | 1.54M | $20.27M |
 Agios Pharmaceuticals, Inc. | AGIO | 3.41M | $126.51M |
 Stoke Therapeutics, Inc. | STOK | 4.04M | $132.14M |
 C4 Therapeutics, Inc. | CCCC | 7.33M | $34.22M |
 Cullinan Therapeutics, Inc. | CGEM | 8.96M | $163.23M |